<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-790
Date of Submission: 2025-04-08

This report was submitted by a Nurse from Sullivan-Wilson Medical Center concerning patient ANON-PX-5773. The subject is an adult male with a significant medical history including migraines, atrial fibrillation. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Sertraline administered via the Intravenous route at a dosage of 105mg, initiated on 2025-02-05 for Major depressive disorder and discontinued on 2025-03-17; Atorvastatin (Statin) administered via the Intravenous route at a dosage of 188mg, initiated on 2025-02-05 for Hypercholesterolemia and discontinued on 2025-03-17.

On approximately 2025-03-14, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Stevens-Johnson syndrome, Pruritus, Maculopapular Rash, Dizziness. The Stevens-Johnson syndrome was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. The Pruritus was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed Republican and advised between. The current patient status regarding this symptom is 'Not Recovered'. The Maculopapular Rash was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. The Dizziness was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed agreement and advised kitchen. The current patient status regarding this symptom is 'Recovering'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive rechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Although seek surface design. Fund wonder bed our. Agent beat put consider data heavy.</data>
report_id: ADR-2025-790
report_date: '2025-04-08'
patient_details:
  patient_id: ANON-PX-5773
  gender: Male
  relevant_history:
  - migraines
  - atrial fibrillation
suspected_drugs:
- drug_name: Sertraline
  dosage: 105mg
  route_of_administration: Intravenous
  start_date: '2025-02-05'
  indication_for_use: Major depressive disorder
  end_date: '2025-03-17'
- drug_name: Atorvastatin
  dosage: 188mg
  route_of_administration: Intravenous
  start_date: '2025-02-05'
  indication_for_use: Hypercholesterolemia
  drug_class: Statin
  end_date: '2025-03-17'
adverse_reactions:
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2025-03-14'
  severity: Life-threatening
  outcome: Unknown
  intervention_required: false
- symptom_name: Pruritus
  onset_date: '2025-03-14'
  severity: Life-threatening
  outcome: Not Recovered
  intervention_required: true
  intervention_details: Prescribed Republican and advised between.
- symptom_name: Maculopapular Rash
  onset_date: '2025-03-14'
  severity: Life-threatening
  outcome: Unknown
  intervention_required: false
- symptom_name: Dizziness
  onset_date: '2025-03-14'
  severity: Moderate
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed agreement and advised kitchen.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive rechallenge
reporting_facility: Sullivan-Wilson Medical Center
reporter_type: Nurse
notes: Although seek surface design. Fund wonder bed our. Agent beat put consider
  data heavy.
